LBBC’s Conference on Metastatic Breast Cancer
In June, Living Beyond Breast Cancer (LBBC) held its Annual Conference on Metastatic Breast Cancer. Due to COVID-19 the event was held virtually. You can watch...
Read MoreMetastatic Breast Cancer at a Young Age
Metastatic breast cancer can happen to anyone, including young people. Most research considers a person “young” if they’ve been diagnosed with...
Read MoreHow Participants are Divided into Treatment Groups in Clinical Trials
Randomization is part of clinical trial design that helps researchers prevent accidental bias in the trial results meaning that no outside factors shifted the...
Read MoreSide Effects of MBC Treatments: Sexual Health Side Effects
MBC treatment aims to extend life but also comes with side effects that can impact quality of life. There are ways to manage the different types of side effects...
Read MoreWhat is ER-Low Breast Cancer?
Did you know that some breast cancers can be defined as estrogen receptor low (ER-low) breast cancer? When you’re first diagnosed, a pathologist runs a...
Read MoreClinical Trials Are Not Only a Last Resort
It’s a myth that you should only join a metastatic breast cancer clinical trial when you have no other treatment options here’s why. In general, you...
Read MoreSpotlight on Metastatic Breast Cancer in Older People
Geriatric oncology is a specialty that focuses on treating and researching cancer in older people. As we age, our bodies are more likely to develop many different...
Read MoreFDA Approves PHESGO
In late June, the FDA approved PHESGO (pertuzumab/ trastuzumab/ hyaluronidase-zzxf), a treatment that can be injected under the skin, to treat metastatic and...
Read MoreHER2 Positive Metastatic Breast Cancer Research Update
The treatment landscape for HER2 positive metastatic breast cancer has been rapidly evolving. Since February, the FDA has approved three new drugs to treat it:...
Read MoreSEARCH OUR SITE
for past articles or specific information.